Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 1, 2013, Pages 127-130

  Kazemi Lomedasht, Fatemeh ^a,b   Rami, Abbas ^b   Zarghami, Nosratollah ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Anti cancer drug; Breast cancer; Drug delivery; Target therapy; Telomerase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA CYCLODEXTRIN; CURCUMIN; MESSENGER RNA; NANOPARTICLE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG SOLUBILITY; GENE EXPRESSION; IC 50; MOLECULAR DYNAMICS; ONCOGENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TELOMERASE REVERSE TRANSCRIPTASE GENE;

EID: 84874961915     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.021     Document Type: Article

References (12)

1. Tarkanyi I, Aradi J. Pharmacological intervention strategies for affecting telomerase activity: Future prospects to treat cancer and degenerative disease. Biochimie 2008;90(1):156-72.
2. Kirkpatrick KL, Ogunkolade W, Elkak AE, Bustin S, Jenkins P, Ghilchick M, et al. hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat 2003;77(3):277-84.
3. Tian N, Gaines Wilson J, Benjamin Zhan F. Female breast cancer mortality clusters within racial groups in the united states. Health Place 2010;16(2):209-18.
4. Nicole MB. Targeting telomerase and telomeres with small molecule anticancer compounds. MMG 445 Basic Biotechnology eJournal 2008;4:72-9.
5. Daybe FV. Uber Curcumin. Den Farbstoff der Curcumawurzzel Ber 1870;3:609.
6. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269(2):199-225.
7. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The indian solid gold. Adv Exp Med Biol 2007;595:1-75.
8. Sharma RA, Gescher A, Steward WP Curcumin: the story so far. Eur J Cancer 2005; 41(13): 1955-68.
9. Yallapu MM, Jaggi M, Chauhan SC. Beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 2010;79(1):113-25.
10. Kazemi F, Zarghami N, Fekri-aval S, Monfaredan A. β-Cyclodextrin-curcumin complex inhibit telomerase gene expression in T47-D breast cancer cell line. Afr J Biotechnol 2011; 83(10): 19481-88.
11. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6(2):E329-57.
12. Yadav R, Sahdeo P, Ramaswamy K, Javaraj R, Chaturvedi M, Lauri V, et al. Cyclodextrin-complexd curcumin exhibits antiinflamatory and anti proliferative activity. Biochem pharmacol 2010; 80(7): 1021-32.